OUR SCIENCE

Fighting cancer through unconventional approaches

Fighting cancer through unconventional approaches

By combining our recombinant antibody-like drug discovery platform and deep understanding of the underlying biology, we aim to develop drugs that recognize cancer cells and then cleanly and selectively destroy them without causing harm to healthy tissues. We examine existing knowledge and new ideas about validated targets (past and present) and expand them with our science to realize great pharmacological potential.
cancer_imv

OUR SCIENCE

Leveraging decades of experience, our team has identified high-value targets and developed biologic agents for effective eradiation of malignant cells.

TARGETING

Targets are present in high density on cancer cells, and are not present on most normal cells.

ANTIBODIES

Recombinant antibody-based proteins developed to induce cell destruction of targeted cells.

BREAKTHROUGH

Innovative mode of tumor eradication.

POTENCY

Unlike ADCs, our molecules do not rely on internalization inside cells, nor on toxic payloads, and thus can kill drug-resistant cells.

MANUFACTURING

Our molecules are fully compatible with standard antibody manufacturing processes, no chemical modification of the protein is involved.

NOT TOXIC

No toxic chemicals, or proteins, nor recruitment of immune cells, which could cause dangerous side effects.